Centerspace
NYSE:CSRREIT - Residential
-$0.16 today
- Market cap
- $944.16M
- Beta
- 0.89
- P/E (TTM)
- 110.2
- EPS (TTM)
- $0.50
- Dividend yield
- 5.63%
Volume 0.16M
Average 0.15M
CSR Investing Cash Flow
Net cash used in or generated by investments in assets, acquisitions, and securities.
CenterspaceNYSE: CSR
Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026
Investing cash flow growth accelerates
Q1 FY2026 investing cash flow of $5.02M (cash outflow) rose 2.8% year over year, ahead of the -42.0% change in trailing-twelve-month investing cash flow. Over 3 fiscal years it compounded at -44.8% a year.
Context
- Investing cash flow amounted to 7.6% of revenue in FY2025, down 11.8 pp from a year earlier.
- Investing cash flow increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +2.8% holds above the trailing-twelve-month pace of -42.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Investing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- (26.87M) USD
- Year-over-year change
- +47.0%
| Period | Period end | Investing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (26.87M) | +47.0% |
| FY2024 | 2024-12-31 | (50.72M) | -142.2% |
| FY2023 | 2023-12-31 | 120.21M | +175.1% |
| FY2022 | 2022-12-31 | (160.09M) | +40.1% |
| FY2021 | 2021-12-31 | (267.23M) | — |
Investing Cash Flow vs competitors
How CSR compares with its peers on the latest reported figures
- CSR's LTM Mar 2026 investing cash flow of $27.01M is the 8th largest of the 9 companies compared; the peer median is $99.32M.
- Its year-over-year change of -42.0% is the 7th highest of 9, against a peer median of +94.6%.
- Investing cash flow amounts to 9.9% of revenue for CSR, versus a peer median of 39.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $2.9B | +469.7% | — | 379.2% | |
| LTM Mar 2026 | $1.65B | +162.8% | — | 117.8% | |
| LTM Mar 2026 | $874.97M | +1541.0% | — | 714.1% | |
| LTM Mar 2026 | $206.06M | +26.5% | +7.6% | 13.6% | |
| LTM Mar 2026 | $183.92M | -18.0% | +420.0% | 32.5% | |
| LTM Mar 2026 | $114.48M | -515.2% | -10.7% | 45.5% | |
| LTM Mar 2026 | $75.9M | +496.1% | +14.8% | 25.8% | |
| LTM Mar 2026 | $27.01M | -42.0% | -44.8% | 9.9% | |
| LTM Mar 2026 | $7.41M | -95.5% | — | 0.9% | |
| Peer median (excluding CSR) | $99.32M | +94.6% | +11.2% | 39.0% | |
Competitors are the stored peer set for CSR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (2.1M) | (17.64M) | 41.97M | (14.19M) | (2.41M) |
| Depreciation & Amortization | 93.11M | 106.21M | 103.17M | 107.65M | 116.57M |
| Deferred Income Tax | (24.68M) | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 2.69M | 2.62M | 3.3M | 3.01M | 3.45M |
| Change in Working Capital | 10.35M | 5K | (2.87M) | (3.46M) | (5.37M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 15.75M | 650K | (2.11M) | 1.44M | 245K |
| Other Working Capital | (5.4M) | (645K) | (760K) | (4.9M) | (5.62M) |
| Other Non-Cash Items | 4.66M | 804K | (56.04M) | 5.23M | (13.78M) |
| Operating Cash Flow | 84.03M | 91.99M | 89.52M | 98.25M | 98.45M |
| Capital Expenditures | (35.88M) | (56.57M) | (58.83M) | (56.65M) | (34.16M) |
| Acquisitions (Net) | 328.06M | 161.32M | 0 | 0 | 0 |
| Purchases of Investments | (292.18M) | (104.67M) | 0 | 0 | 0 |
| Sales of Investments | 33.82M | 41K | 223.26M | 18.83M | 132.77M |
| Other Investing Activities | (301.04M) | (160.09M) | 120.21M | (69.54M) | (159.63M) |
| Investing Cash Flow | (267.23M) | (160.09M) | 120.21M | (50.72M) | (26.87M) |
| Debt Repayment | 113.12M | 108.07M | (140.25M) | 6.5M | 10.79M |
| Common Stock Issued | 156.04M | 31.44M | 0 | 112.07M | 0 |
| Common Stock Repurchased | 0 | (33.2M) | (11.58M) | (4.7M) | (4.63M) |
| Dividends Paid | (45.56M) | (51.53M) | (50.81M) | (51.25M) | (51.56M) |
| Other Financing Activities | (9.09M) | (13.41M) | (9.72M) | (9.25M) | (23.66M) |
| Financing Cash Flow | 214.51M | 41.37M | (212.35M) | (43.67M) | (69.06M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 31.32M | (26.73M) | (2.62M) | 3.86M | 2.52M |
| Free Cash Flow | 48.15M | 35.42M | 30.7M | 41.59M | 64.29M |
Centerspace
NYSE:CSR
Intrinsic Alpha fair value
Locked
Current Price
$56.12
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.